Monkeypox Disease Diagnostics Market Size, Share, By Testing Method (Real-Time/Conventional PCR, Sequencing, Serological Tests, Viral Culture, Immunohistochemistry, and Others), Sample Type (Skin Lesion Swabs, Exudates, Roofs, and Crusts), End-Use (Hospitals & Clinics, Diagnostic Laboratories, and Others), and Region - Trends, Analysis, and Forecast till 2035

Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. 

North America has the biggest monkeypox disease diagnostics market share. This is due to this region’s strong healthcare infrastructure, government support, leading medical technology companies, rising incidences of monkeypox, and presence of key market players, thereby dominating the market.

Asia Pacific is considered to have the fastest growing market, during the forecast period. This is due to this region’s rapid economic development, a rising number of monkeypox infections, a growing healthcare spending, dense urbanization and population growth, and increasing research and development for developing therapeutic options.